Documentos de Werneck G.L. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área de conocimiento: "Inmunología"

Subtipo de publicación

Publisher

Nature Communications(1)

Nature Medicine(1)

The Lancet Infectious Diseases(1)

The Lancet Regional Health - Americas(1)

Área temáticas

Medicina y salud(4)

Farmacología y terapéutica(2)

Enfermedades(1)

Fisiología humana(1)

Área de conocimiento

Epidemiología(1)

Salud pública(1)

Año de Publicación

Origen

Palabras Claves

EFFECTIVENESS(1)

Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil

Abstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19

Palabras claves:

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Abstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARS

Palabras claves:

Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.

Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

Abstract: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine eff

Palabras claves:

CoronaVac, covid-19, EFFECTIVENESS, Vaccine, Vaxzevria

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Barros J.V., Flores-Ortiz R.J., Ichihara M.Y.T., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Oliveira V.D.A., Penna G.O., Pescarini J.M., Werneck G.L.

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

Abstract: There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19)

Palabras claves:

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Flores-Ortiz R.J., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Sheikh A., Werneck G.L.